{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:39:50Z","timestamp":1786984790729,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2016 BP 00204"],"award-info":[{"award-number":["2016 BP 00204"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.arbr.2019.11.013","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T15:57:21Z","timestamp":1594051041000},"page":"446-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out"],"prefix":"10.1016","volume":"56","author":[{"given":"Emilio","family":"Letang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogieleum","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther C.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paquita","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razia","family":"Hassan-Moosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Cresswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto L.","family":"Garc\u00eda-Basteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbr.2019.11.013_bib0420","series-title":"WHO | Global tuberculosis report 2018","first-page":"1","year":"2018"},{"key":"10.1016\/j.arbr.2019.11.013_bib0425","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ije\/dyy144","article-title":"What is the true tuberculosis mortality burden? Differences in estimates by the World Health Organization and the Global Burden of Disease study","volume":"47","author":"Garc\u00eda-Basteiro","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 3(s3)","key":"10.1016\/j.arbr.2019.11.013_bib0430","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1086\/651492","article-title":"HIV infection-associated tuberculosis: the epidemiology and the response","volume":"50","author":"Getahun","year":"2010","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.arbr.2019.11.013_bib0435","doi-asserted-by":"crossref","first-page":"17396","DOI":"10.7448\/IAS.15.2.17396","article-title":"HIV and tuberculosis\u2013science and implementation to turn the tide and reduce deaths","volume":"15","author":"Harries","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.arbr.2019.11.013_bib0440","series-title":"The pathogenesis of tuberculosis","author":"Rich","year":"1954"},{"key":"10.1016\/j.arbr.2019.11.013_bib0445","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s11095-009-9957-4","article-title":"Inhaled drug delivery for tuberculosis therapy","volume":"26","author":"Muttil","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.arbr.2019.11.013_bib0450","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"Pt 2","key":"10.1016\/j.arbr.2019.11.013_bib0455","first-page":"25","article-title":"Pathogenesis of pulmonary tuberculosis","volume":"125","author":"Dannenberg","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0460","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"Orme","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.arbr.2019.11.013_bib0465","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1128\/AAC.02346-12","article-title":"Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis","volume":"57","author":"Dharmadhikari","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbr.2019.11.013_bib0470","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/S0882-0546(03)00072-0","article-title":"Clinical and radiographic features of HIV-related tuberculosis","volume":"18","author":"Burman","year":"2003","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.arbr.2019.11.013_bib0475","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/2049-632X.12108","article-title":"HIV-Mycobacterium tuberculosis co-infection: a \u201cdanger-couple model\u201d of disease pathogenesis","volume":"70","author":"Shankar","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0480","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","article-title":"Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection","volume":"148","author":"Jones","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0485","first-page":"244","article-title":"Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients","volume":"77","author":"Di Perri","year":"1996","journal-title":"Tuber Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.arbr.2019.11.013_bib0490","doi-asserted-by":"crossref","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","article-title":"Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response","volume":"204","author":"Achkar","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0495","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.arbr.2019.11.013_bib0500","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0505","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/510080","article-title":"Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission","volume":"44","author":"Elzi","year":"2007","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.arbr.2019.11.013_bib0510","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","first-page":"1","year":"2018"},{"key":"10.1016\/j.arbr.2019.11.013_bib0515","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00002030-200305020-00027","article-title":"Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy","volume":"17","author":"Fisk","year":"2003","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.arbr.2019.11.013_bib0520","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cix745","article-title":"QuantiFERON-TB gold in-tube as a confirmatory test for tuberculin skin test in tuberculosis contact tracing: a noninferiority clinical trial","volume":"66","author":"Mu\u00f1oz","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.arbr.2019.11.013_bib0525","series-title":"Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations\u20132016 update","year":"2016"},{"key":"10.1016\/j.arbr.2019.11.013_bib0530","doi-asserted-by":"crossref","unstructured":"Lienhardt C, Raviglione M, infectious MSJ of, 2012. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. academic.oup.com.","DOI":"10.1093\/infdis\/jis034"},{"key":"10.1016\/j.arbr.2019.11.013_bib0535","series-title":"Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. academic.oup.com","author":"Bassett","year":"2010"},{"key":"10.1016\/j.arbr.2019.11.013_bib0540","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1258\/004947506776593396","article-title":"HIV-TB: epidemiology, clinical features and diagnosis of smear-negativeTB","volume":"36","author":"Keshinro","year":"2016","journal-title":"Trop Doct"},{"key":"10.1016\/j.arbr.2019.11.013_bib0545","series-title":"Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults-The Cochrane Database of Systematic Reviews published by John \u2026","author":"Steingart","year":"2014"},{"key":"10.1016\/j.arbr.2019.11.013_bib0550","unstructured":"World Health Organization \u2013 Policy statement: automated real-time \u2026, 2011. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB \u2026. cabdirect.org."},{"key":"10.1016\/j.arbr.2019.11.013_bib0555","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0560","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(17)30474-7","article-title":"Diagnostic accuracy of Xpert MTB\/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study","volume":"18","author":"Bahr","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0565","series-title":"WHO meeting report of a technical expert consultation: non-inferiority analysis of Xpert M.T","year":"2017"},{"key":"10.1016\/j.arbr.2019.11.013_bib0570","series-title":"The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV: policy \u2026","year":"2015"},{"key":"10.1016\/j.arbr.2019.11.013_bib0575","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","article-title":"Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial","volume":"392","author":"Gupta-Wright","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.arbr.2019.11.013_bib0580","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/JCM.00486-15","article-title":"Rapid whole-genome sequencing of mycobacterium tuberculosis isolates directly from clinical samples","volume":"53","author":"Brown","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.arbr.2019.11.013_bib0585","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/JCM.00358-17","article-title":"Real-time sequencing of mycobacterium tuberculosis: are we there yet?","volume":"55","author":"Lee","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.arbr.2019.11.013_bib0590","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"Dye","year":"2008","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.arbr.2019.11.013_bib0595","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0600","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.arbr.2019.11.013_bib0605","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.5588\/ijtld.18.0168","article-title":"Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review","volume":"22","author":"Hamada","year":"2018","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"Suppl. 6","key":"10.1016\/j.arbr.2019.11.013_bib0610","first-page":"2023","article-title":"Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children","volume":"18","author":"Rabie","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.arbr.2019.11.013_bib0615","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0620","doi-asserted-by":"crossref","first-page":"723","DOI":"10.15585\/mmwr.mm6725a5","article-title":"Update of recommendations for use of once-weekly isoniazid-rifapentine regimen to treat latent mycobacterium tuberculosis infection","volume":"67","author":"Borisov","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arbr.2019.11.013_bib0625","series-title":"UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic","first-page":"1","year":"2014"},{"key":"10.1016\/j.arbr.2019.11.013_bib0630","doi-asserted-by":"crossref","first-page":"h882","DOI":"10.1136\/bmj.h882","article-title":"Multidrug resistant tuberculosis","volume":"350","author":"Millard","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.arbr.2019.11.013_bib0635","series-title":"Joint meeting of the global GLC Committee and the MDR-TB Core Group","year":"2013"},{"key":"10.1016\/j.arbr.2019.11.013_bib0640","series-title":"The Hague, Netherlands","article-title":"Sustained high rate of successful treatment outcomes: interim results of 75 patients in the Nix-TB clinical study of pretomanid, bedaquiline and linezolid","author":"Conradie","year":"2018"},{"key":"10.1016\/j.arbr.2019.11.013_bib0645","series-title":"Guidelines for the treatment of drug-susceptible tuberculosis and patient care","year":"2017"},{"key":"10.1016\/j.arbr.2019.11.013_bib0650","article-title":"Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and Hiv: a multicenter, noncomparative, open-label, randomized trial","author":"Dooley","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.arbr.2019.11.013_bib0655","article-title":"BHIVA guidelines for the management of TB in adults living with HIV [Internet]","author":"Pozniak","year":"2018","journal-title":"BHIVA"},{"key":"10.1016\/j.arbr.2019.11.013_bib0660","series-title":"IAS 2019","article-title":"Virologic efficacy of raltegravir vs. efavirenz-based antiretroviral treatment in HIV1-infected adults with tuberculosis: W48 results of the ANRS 12300 Reflate TB2 trial","author":"De Castro","year":"2019"},{"key":"10.1016\/j.arbr.2019.11.013_bib0665","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0670","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1473-3099(14)70733-9","article-title":"Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial","volume":"14","author":"Mfinanga","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0675","series-title":"Dis MFLI, a. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","author":"Meintjes","year":"2010"},{"key":"10.1016\/j.arbr.2019.11.013_bib0680","doi-asserted-by":"crossref","first-page":"ofx274","DOI":"10.1093\/ofid\/ofx274","article-title":"Cryptococcal disease in the era of \u201cTest and Treat\u201d: is there cause for concern?","volume":"5","author":"Abassi","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0685","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.arbr.2019.11.013_bib0690","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1800762","article-title":"Prednisone for the prevention of paradoxical tuberculosis-associated IRIS","volume":"20","author":"Meintjes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0695","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/cir230","article-title":"Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)\u2013associated tuberculous meningitis","volume":"52","author":"T\u00f6r\u00f6k","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.arbr.2019.11.013_bib0700","first-page":"CD002244","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"4","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbr.2019.11.013_bib0705","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0710","doi-asserted-by":"crossref","first-page":"31","DOI":"10.12688\/wellcomeopenres.14006.2","article-title":"Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): study protocol for a randomised controlled trial","volume":"3","author":"Donovan","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.arbr.2019.11.013_bib0715","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","article-title":"Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial","volume":"293","author":"Misra","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arbr.2019.11.013_bib0720","series-title":"Miles to go\u2014closing gaps, breaking barriers, righting injustices","author":"UNAIDS","year":"2018"},{"key":"10.1016\/j.arbr.2019.11.013_bib0725","unstructured":"World Health Organization \u2013 WHO policy on collaborative TB\/HIV activities \u2026, 2012. WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders."},{"key":"10.1016\/j.arbr.2019.11.013_bib0730","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.lpm.2017.01.017","article-title":"The cursed duet today: tuberculosis and HIV-coinfection","volume":"46","author":"Tiberi","year":"2017","journal-title":"Presse M\u00e9dicale"},{"key":"10.1016\/j.arbr.2019.11.013_bib0735","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0000000000001560","article-title":"Incidence of tuberculosis among HIV-positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa","volume":"77","author":"Bock","year":"2018","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"Suppl_2","key":"10.1016\/j.arbr.2019.11.013_bib0740","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/cid\/cix1140","article-title":"The continuing burden of advanced HIV disease over 10 years of increasing antiretroviral therapy coverage in South Africa","volume":"66","author":"Osler","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"Suppl_2","key":"10.1016\/j.arbr.2019.11.013_bib0745","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1093\/cid\/cix1141","article-title":"Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial","volume":"66","author":"Post","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.arbr.2019.11.013_bib0750","series-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017","year":"2017"},{"key":"10.1016\/j.arbr.2019.11.013_bib0755","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.4081\/idr.2016.6569","article-title":"New antituberculosis drugs: from clinical trial to programmatic use","volume":"8","author":"Gualano","year":"2016","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.arbr.2019.11.013_bib0760","doi-asserted-by":"crossref","first-page":"e0155968","DOI":"10.1371\/journal.pone.0155968","article-title":"Programmatic management of drug-resistant tuberculosis: an updated research agenda","volume":"11","author":"Mitnick","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arbr.2019.11.013_bib0765","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann Intern Med"},{"issue":"Pt 2","key":"10.1016\/j.arbr.2019.11.013_bib0770","first-page":"e13","article-title":"Tuberculosis elimination and the challenge of latent tuberculosis","volume":"46","author":"Matteelli","year":"2017","journal-title":"Presse Medicale Paris Fr 1983"},{"key":"10.1016\/j.arbr.2019.11.013_bib0775","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0780","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-rifapentine for latent tuberculosis infection: a systematic review and meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.arbr.2019.11.013_bib0785","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1758-2652-12-23","article-title":"Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV\/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years","volume":"12","author":"Cohen","year":"2009","journal-title":"J Int AIDS Soc"},{"issue":"Suppl.1","key":"10.1016\/j.arbr.2019.11.013_bib0790","first-page":"S14","article-title":"Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya","volume":"7","author":"Nganda","year":"2003","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"Suppl.1","key":"10.1016\/j.arbr.2019.11.013_bib0795","first-page":"S29","article-title":"Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi","volume":"7","author":"Floyd","year":"2003","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"Suppl.1","key":"10.1016\/j.arbr.2019.11.013_bib0800","first-page":"S56","article-title":"Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa","volume":"7","author":"Sinanovic","year":"2003","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0805","doi-asserted-by":"crossref","first-page":"e0196831","DOI":"10.1371\/journal.pone.0196831","article-title":"High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland","volume":"13","author":"Pathmanathan","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arbr.2019.11.013_bib0810","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.5588\/ijtld.12.0593","article-title":"Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin","volume":"17","author":"Ferroussier","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0815","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.5588\/ijtld.12.0592","article-title":"Integrating HIV testing and care into tuberculosis services in Benin: programmatic aspects","volume":"17","author":"Ferroussier","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.arbr.2019.11.013_bib0820","unstructured":"MSF MF, Brussels, 2016. Out of Focus: How millions of people in West and Central Africa are being left out of the global HIV response."},{"key":"10.1016\/j.arbr.2019.11.013_bib0825","doi-asserted-by":"crossref","first-page":"565049","DOI":"10.1155\/2012\/565049","article-title":"A model of tuberculosis screening for pregnant women in resource-limited settings using Xpert MTB\/RIF","volume":"2012","author":"Turnbull","year":"2012","journal-title":"J Pregnancy"},{"key":"10.1016\/j.arbr.2019.11.013_bib0830","series-title":"The end TB strategy","year":"2015"}],"container-title":["Archivos de Bronconeumolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1579212920301518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1579212920301518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:05:55Z","timestamp":1761624355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1579212920301518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1579212920301518"],"URL":"https:\/\/doi.org\/10.1016\/j.arbr.2019.11.013","relation":{},"ISSN":["1579-2129"],"issn-type":[{"value":"1579-2129","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbr.2019.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}